End-of-day quote
Other stock markets
|
||
- USD | - |
|
17/06 | MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc. | CI |
23/05 | MyMD Pharmaceuticals, Inc. amended terms of the transaction | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 5.09Cr 425.2Cr |
---|---|---|---|---|---|
Net income 2022 | -40L -33Cr | Net income 2023 | -40L -33Cr | EV / Sales 2022 | - |
Net cash position 2022 | 8.54Cr 712.92Cr | Net cash position 2023 | 6.8Cr 568Cr | EV / Sales 2023 | - |
P/E ratio 2022 |
-8.53
x | P/E ratio 2023 |
-13.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.95% |
Managers | Title | Age | Since |
---|---|---|---|
Joshua Silverman
CEO | Chief Executive Officer | 54 | 15/22/15 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 01/15/01 |
José Iglesias
CTO | Chief Tech/Sci/R&D Officer | - | 10/20/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Weinstein
BRD | Director/Board Member | 64 | 14/22/14 |
Joshua Silverman
CEO | Chief Executive Officer | 54 | 15/22/15 |
Wayne Walker
BRD | Director/Board Member | 65 | 28/22/28 |
1st Jan change | Capi. | |
---|---|---|
+56.89% | 82TCr | |
+39.52% | 63TCr | |
-6.55% | 35TCr | |
+15.99% | 32TCr | |
+7.92% | 30TCr | |
+13.74% | 24TCr | |
+13.83% | 22TCr | |
-0.49% | 22TCr | |
+7.94% | 17TCr |